Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study

INTRODUCTION: Reducing intraocular pressure (IOP), the only modifiable risk factor for open-angle glaucoma (OAG), is important for the preservation of vision and slowing of disease progression. Preservative-free tafluprost (0.0015%)/timolol (0.5%) fixed combination (PF Taf-T FC) is an approved combi...

詳細記述

保存先:
書誌詳細
出版年:Adv Ther
主要な著者: Ansari, Ejaz, Pavicic-Astalos, Jasna, Ayan, Filis, King, Anthony J., Kinsella, Matthew, Ng, Eugene, Nita, Anca
フォーマット: Artigo
言語:Inglês
出版事項: Springer Healthcare 2021
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8190000/
https://ncbi.nlm.nih.gov/pubmed/33886093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01725-7
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料